HEPATIC STEATOSIS
Clinical trials for HEPATIC STEATOSIS explained in plain language.
Never miss a new study
Get alerted when new HEPATIC STEATOSIS trials appear
Sign up with your email to follow new studies for HEPATIC STEATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection aims to tackle fatty liver
Disease control Recruiting nowThis early-stage trial tests an experimental drug called NNC0581-0001 in 48 adults with fatty liver and suspected liver inflammation. Participants receive three monthly injections of either the drug or a placebo. The main goal is to check safety and how the drug moves through the…
Matched conditions: HEPATIC STEATOSIS
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug shows promise in shrinking fatty liver
Disease control Recruiting nowThis study tests whether a daily injection of tesamorelin can safely reduce liver fat in adults with metabolic fatty liver disease (MASLD). About 120 participants will receive either the drug or a placebo for 52 weeks, along with lifestyle advice. The main goal is to measure chan…
Matched conditions: HEPATIC STEATOSIS
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can new scanners spot fatty liver without an MRI?
Diagnosis Recruiting nowThis study compares two newer imaging methods—photon-counting CT and ultrasound—against the standard MRI to see how well they detect fat and scarring in the liver. About 45 adults with liver disease will receive all three scans. The goal is to find a faster, cheaper, and equally …
Matched conditions: HEPATIC STEATOSIS
Phase: NA • Sponsor: Duke University • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
New ultrasound could replace painful liver biopsies
Diagnosis Recruiting nowThis study is testing a new ultrasound technique called visual transient elastography (ViTE) to measure liver fat and scarring in people with chronic liver injury. Researchers will compare the ultrasound results to the standard liver biopsy to see how accurate the new method is. …
Matched conditions: HEPATIC STEATOSIS
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
Could a simple ultrasound replace costly MRIs for fatty liver diagnosis?
Diagnosis Recruiting nowThis study is testing a new ultrasound technology called DeepUSFF to measure fat in the liver of people with metabolic fatty liver disease (MASLD). Researchers will compare the ultrasound results to MRI scans, which are the current gold standard. If the ultrasound works well, it …
Matched conditions: HEPATIC STEATOSIS
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
Liver biopsies reveal Fat-Busting secrets in alcohol detox
Knowledge-focused Recruiting nowThis study looks at how the liver processes fat in people with alcohol use disorder who are quitting drinking. Researchers will take two small liver samples—one early in detox and one after four weeks—to compare gene activity. The goal is to understand how the liver clears fat wh…
Matched conditions: HEPATIC STEATOSIS
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jul 01, 2026 23:00 UTC
-
Small study to uncover how exercise changes Liver's sugar output in diabetes
Knowledge-focused Recruiting nowThis study looks at how exercise changes the amount of sugar the liver makes in people with type 2 diabetes and fatty liver disease. Researchers will measure liver sugar production during rest and exercise in 12 adults aged 25-55. The goal is to better understand how exercise hel…
Matched conditions: HEPATIC STEATOSIS
Phase: NA • Sponsor: AdventHealth Translational Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC